Perspective Therapeutics (FRA:AAJ) 3-Year Book Growth Rate : 47.60% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics 3-Year Book Growth Rate?

Perspective Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €0.36.

During the past 12 months, Perspective Therapeutics's average Book Value per Share Growth Rate was -7.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 47.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 37.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Perspective Therapeutics was 74.80% per year. The lowest was -49.10% per year. And the median was 13.70% per year.

Competitive Comparison of Perspective Therapeutics's 3-Year Book Growth Rate

For the Medical Devices subindustry, Perspective Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perspective Therapeutics's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's 3-Year Book Growth Rate falls into.

Perspective Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Perspective Therapeutics (FRA:AAJ) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Perspective Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ:Germany

Address

350 Hills Street, Suite 106, Richland, WA, USA, 99354

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines